Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep 4;8(1):331.
doi: 10.1038/s41392-023-01595-1.

From Tpex to Tex: a journey through CD8+ T cell responses in cancer immunotherapy

Julia M Messmer #  1 , Maike Effern #  1 , Michael Hölzel  2
Affiliations
Comment

From Tpex to Tex: a journey through CD8+ T cell responses in cancer immunotherapy

Julia M Messmer et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Neoadjuvant cancer immunotherapy trials and translational companion studies like Rahim et al. provide unique opportunities to guide the development and benchmarking of pre-clinical models to reiterate knowledge and improve the clinical trial design. Figure created with BioRender.com
See this image and copyright information in PMC

Comment on

References

    1. Rahim MK, et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell. 2023;186:1127–1143.e18. doi: 10.1016/j.cell.2023.02.021. - DOI - PMC - PubMed
    1. Schenkel JM, et al. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes. Immunity. 2021;54:2338–2353.e6. doi: 10.1016/j.immuni.2021.08.026. - DOI - PMC - PubMed
    1. Connolly KA, et al. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 2021;6:eabg7836. doi: 10.1126/sciimmunol.abg7836. - DOI - PMC - PubMed
    1. Reticker-Flynn NE, et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell. 2022;185:1924–1942.e23. doi: 10.1016/j.cell.2022.04.019. - DOI - PMC - PubMed
    1. Saddawi-Konefka R, et al. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat. Commun. 2022;13:4298. doi: 10.1038/s41467-022-31941-w. - DOI - PMC - PubMed

Publication types